Schedule 13D ownership disclosure
Intiva BioPharma Inc.
Security class unavailable · CUSIP: 46116E103
Event date: 2017-11-29
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 24,000,000
- Percent of class
- 55.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001214659-17-007051
- Form type
- SC 13D
- Filer
- NEXIEN BIOPHARMA, INC.
- CIK
- CIK 1625288
- Filed
- Dec 01, 2017
- Reporting period
- Nov 29, 2017
- Description
- Schedule 13D beneficial ownership